Gene · 50652
PCA3: prostate cancer associated 3
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. PCA3: prostate cancer associated 3. Genes, record 50652. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/50652
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants746
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | PCA3 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 32 | 2025 |
| U01CA113913 | Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern | 26 | 2025 |
| P50CA092629 | SPORE in Prostate Cancer | 22 | 2025 |
| P50CA186786 | Michigan Prostate SPORE 2025-2030 | 18 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 15 | 2025 |
| U24CA086368 | The Early Detection Research Network: Data Management and Coordinating Center | 14 | 2025 |
| P30CA054174 | Mays Cancer Center at UT Health SA | 12 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 8 | 2025 |
| P50CA097186 | The Pacific Northwest Prostate Cancer SPORE | 6 | 2025 |
| P30CA046592 | University of Michigan Rogel Cancer Center Support Grant 2023-2028 | 5 | 2025 |
1 to 10 of 746Source NIH's project files
See all 746 nih grantsPapers2,438
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| lncRNA PCA3 plays a key role in colon cancer occurrence and development. | Arch Med Sci | 2026 | 42540560 | PubTator, text mining | PubMed |
| Morphomechanically-Informed Spatial Curvature Sequencing in Prostate Cancer. | bioRxiv | 2026 | 42539092 | PubTator, text mining | PubMed |
| Innovations in Diagnosis Immunotherapy and Combination Therapy of Prostate Cancer: A Patent-driven Analysis. | Recent Pat Anticancer Drug Discov | 2026 | 42515880 | PubTator, text mining | PubMed |
| Transcriptome-wide profiling of cystic and solid vestibular schwannomas reveals candidate long non-coding RNA signatures. | Mol Biol Rep | 2026 | 42507076 | PubTator, text mining | PubMed |
| Cut-and-Bind Colorimetric Detection of Viral and Non-Coding RNAs Using CRISPR/Cas12a with Zinc Finger-Facilitated Gold Nanoparticle Assembly. | ACS Sens | 2026 | 42485003 | PubTator, text mining | PubMed |
| Sensitive detection of prostate cancer antigen 3 (PCA3) in urine based upon CRISPR/Cas12a and gold nanorods (AuNRs). | Spectrochim Acta A Mol Biomol Spectrosc | 2026 | 42391902 | PubTator, text mining | PubMed |
| Multifactorial diagnostic model combining SAT-PCA3 in prostate cancer. | Discov Oncol | 2026 | 42337216 | PubTator, text mining | PubMed |
| Extracellular vesicles in prostate cancer: current understanding and future perspectives. | J Natl Cancer Cent | 2026 | 42282127 | PubTator, text mining | PubMed |
| Electrochemical biosensor-based strategies for sensitive detection of prostate cancer biomarkers. | Clin Chim Acta | 2026 | 42235733 | PubTator, text mining | PubMed |
| Integrative advances in biomarker-driven prostate cancer management from genomic discovery to precision oncology. | Discov Oncol | 2026 | 42189429 | PubTator, text mining | PubMed |
1 to 10 of 2,438
See all 2,438 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/50652
GET https://conductscience.org/api/genes/v1/50652/grants?page=2